Analysis of Corticotropin Products using the USP Rat-based Bioassay

NOTICE OF INTENT TO SOLE SOURCE

THIS IS NOT A REQUEST FOR QUOTATIONS. This is a notice of intent to award a Stand-Alone Sole Source Firm Fixed-Price Purchase Order.

The Food and Drug Administration's Office of Acquisition and Grant Services intends to issue a sole source award to: QualTechLabs, Inc. to perform Analysis of Corticotropin Products using the United States Pharmacopeia (USP) Rate-based Bioassay.

The proposed action is for services for which the Government intends to solicit and negotiate with only one source under Statutory Authority: FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services will satisfy Agency requirements; Citation: 10 U.S.C. 2304(c)(1) or 41 U.S.C. 253 (c)(1). The estimated dollar value for this action is not expected to exceed $150,000. The projected award date is June 25, 2015.

A solicitation will not be issued in conjunction with the notice of intent. Interested entities may identify their interest and capability to respond to the requirement or submit quotes. The FDA will review all responses received; however, the Government retains the sole discretion not to further compete the proposed acquisition based on responses to this notice. Information can be sent to William Lee at William.Lee@fda.hhs.gov. No telephone or facsimile requests will be accepted.